Table 1 Clinical characteristics of the study population.
From: Maternal total cell-free DNA in preeclampsia with and without intrauterine growth restriction
Characteristics | Controls | PE | GH | P† | Pa‡ | Pb‡ |
|---|---|---|---|---|---|---|
Second trimester | (n = 78) | (n = 29) | (n = 12) | |||
Maternal age (years) | 33.5 ± 3.5 | 35.5 ± 3.7 | 36.3 ± 4.3 | 0.007 | 0.028 | 0.029 |
Nulliparity | 9 (29.0%) | 8 (27.6%) | 4 (33.3%) | 0.93 | 1.00 | 1.00 |
GA at sampling (weeks) | 21.6 ± 4.2 | 20.0 ± 3.9 | 20.0 ± 4.2 | 0.13 | 0.13 | 0.38 |
BMI at sampling (kg/m2) | 22.6 ± 2.4 | 24.2 ± 3.2 | 26.8 ± 6.0 | < .0001 | 0.03 | < .0001 |
GA at delivery (weeks) | 39.5 ± 1.0 | 37.8 ± 2.6 | 38.8 ± 1.4 | 0.003 | 0.001 | 0.50 |
Birthweight (g) | 3,245 ± 336 | 2,785 ± 767 | 2,961 ± 282 | 0.008 | 0.004 | 0.24 |
Third trimester | (n = 58) | (n = 20) | (n = 7) | |||
Maternal age (years) | 34.2 ± 3.5 | 34.5 ± 3.4 | 36.0 ± 2.6 | 0.41 | 0.93 | 0.33 |
Nulliparity | 10 (52.6%) | 9 (45.0%) | 2 (28.6%) | 0.61 | 0.63 | 0.63 |
GA at sampling (weeks) | 36.8 ± 0.7 | 36.4 ± 2.1 | 37.5 ± 1.5 | 0.12 | 0.37 | 0.30 |
BMI at sampling (kg/m2) | 25.6 ± 2.6 | 28.2 ± 3.5 | 29.6 ± 4.1 | < .0001 | 0.002 | 0.002 |
GA at delivery (weeks) | 39.7 ± 1.1 | 37.3 ± 2.2 | 39.3 ± 1.1 | < .001 | < .0001 | 0.81 |
Birthweight (g) | 3,281 ± 360 | 2,668 ± 610 | 3,122 ± 337 | 0.001 | < .001 | 0.68 |